3Lun·

The bonus needs to be invested

Hello Community,

My bonus will hopefully arrive at the end of April and of course I want to invest it. I'm currently toying with the idea of dividing it up roughly as follows:

25% in $IWDA (+0,28 %) / MSCI World
15% in $MEUD (+0,28 %) / EuroStoxx Europe 600
10% in $BTC (+0,79 %)

For the rest, I would like to lower my entry prices depending on the market situation:

Possible first entries would be the following:

In the end, one or the other will certainly be thrown out, as I don't get a million-dollar bonus here 😥. The investment period is > 15 years, so I'm not even trying to time it here, unless the prices have gone up 40% by the end of April, which I'm not assuming. I am well aware that the MSCI World already tracks a lot of the individual stocks.

Do you still have any exciting quality stocks that are worth a look?

Thanks!

2

4 Comentarios

Moritz@leveragegrinding

3Lun

$1810 Xiaomi
$AIR Airbus

•

6

•

Mostrar respuesta

Aktien Stammtisch

@Aktien_Stammtisch

5Lun·

BostonScientific Q4 2024 EarningsReport Summary

$BSX (+0,22 %)

💼 Performance Overview

Boston Scientific reported 22.40% YoY revenue growth, fueled by strong demand in Cardiovascular (+28.80%) and MedSurg (+12.40%) segments. The company achieved a 14.80% operating margin, reflecting stable operational performance despite increased expenses.

📊 Key Financial Metrics (YoY Growth)

▫ Revenue: $4.56B vs. $3.73B (+22.40%)

▫ Net Income: $566.00M vs. $504.00M (+12.30%)

▫ Adj. EPS: $0.70 vs. $0.55 (+27.27%)

▫ Gross Margin: 67.85% (-0.73pp)

▫ Operating Margin: 14.80% (-0.30pp)

📍 Segment Breakdown

▫ Cardiovascular: $2.94B (+28.80%)

▫ MedSurg: $1.62B (+12.40%)

📈 Future Outlook

▫ FY 2025 Revenue Guidance: $18.84B - $19.16B (+12.50% to +14.50% YoY)

▫ FY 2025 Adj. EPS Guidance: $2.80 - $2.87